JohnMatthewRingmanMD
Neurology • Los Angeles, CAProfessor of Neurology at the Memory and Aging Center at the Keck School of Medicine of USC
Dr. Ringman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 3000
Los Angeles, CA 90033Phone+1 323-457-5710Fax+1 323-442-5736
Education & Training
Baylor College of MedicineResidency, Neurology, 1994 - 1997- Baylor College of MedicineInternship, Internal Medicine, 1993 - 1994
McGill University Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1997 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Curcumin in Patients With Mild to Moderate Alzheimer's Disease Start of enrollment: 2003 Jul 01
- Dominantly Inherited Alzheimer Network (DIAN) Start of enrollment: 2009 Jan 01
- A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Neuropathology of trisomy 21 mosaicism in a case with early-onset dementia.Phong T Ngo, Jesse R Pascual, Sierra Wright, Christopher K Williams, Shino Magaki
Alzheimer's & Dementia. 2024-12-10 - CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease.Yuanyuan Shen, Jigyasha Timsina, Gyujin Heo, Aleksandra Beric, Muhammad Ali
Cell. 2024-10-31 - Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults.Joey A Contreras, Kimiko Fujisaki, Nancy E Ortega, Giuseppe Barisano, Abhay Sagare
Brain Imaging and Behavior. 2024-09-10
Press Mentions
Stunning Diagnostic Accuracy from a Plasma Protein Panel?June 11th, 2021
What Is My Risk for Alzheimer’s Disease?March 1st, 2018
Supplements Are a $30 Billion Racket—Here’s What Experts Actually RecommendFebruary 20th, 2018- Join now to see all
Grant Support
- Clinical CoreNational Institute On Aging2010–2012
- UCLA Alzeheimer'S Disease Research CenterNational Institute On Aging2010
- Behavioral And Neurochemical Correlates Of Presenilin-1 Mutation StatusNational Center For Research Resources2006–2010
- A Phase II, Double-Blind, Placebo-Controlled Study Of The Safety And TolerabilNational Center For Research Resources2005–2009
- Clinical Trial: -KNational Center For Research Resources2008
- Evaluation Of The Safety, Tolerability And Impact On Biomarkers Of Anti-OxidaNational Center For Research Resources2007–2008
- #Name?National Center For Research Resources2007
- High Dose Supplements To Reduce Homocysteine And Slow The Rate Of CognitiveNational Center For Research Resources2005–2007
- Treatment Of Agitation/Psychosis In Dementia/Parkingsonism (Tap/Dap)National Center For Research Resources2005–2006
- KNational Center For Research Resources2005–2006
- Depression In Alzheimer'S Disease (DAD)National Center For Research Resources2005–2006
- FMRI In Pre-Symptomatic Ps1-Related Alzheimer'S DiseaseNational Institute On Aging2003–2005
- FMRI In Pre-Symptomatic Ps1-Related Alzheimer'S DiseaseNational Institute On Aging2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
